Detalhe da pesquisa
1.
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
Liver Int
; 44(5): 1129-1141, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426611
2.
Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions.
Liver Int
; 43(6): 1170-1182, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017559
3.
J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD.
Nutr Metab Cardiovasc Dis
; 32(5): 1259-1265, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260312
4.
Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
J Nanobiotechnology
; 20(1): 349, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35897102
5.
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.
J Gastroenterol Hepatol
; 36(10): 2925-2934, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031913
6.
A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia.
J Clin Endocrinol Metab
; 109(6): 1540-1549, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124275
7.
Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis.
Hepatobiliary Surg Nutr
; 12(5): 645-657, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886189
8.
AutoFibroNet: A deep learning and multi-photon microscopy-derived automated network for liver fibrosis quantification in MAFLD.
Aliment Pharmacol Ther
; 58(6): 573-584, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403450
9.
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.
Hepatobiliary Surg Nutr
; 12(4): 507-522, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600991
10.
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD.
Hepatol Int
; 17(1): 190-201, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152131
11.
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
Aliment Pharmacol Ther
; 57(8): 872-885, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670060
12.
Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case-control study.
Eur J Gastroenterol Hepatol
; 34(8): 838-843, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694803
13.
PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.
J Clin Transl Hepatol
; 10(3): 439-448, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836754
14.
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.
Metabolism
; 128: 154958, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958817
15.
Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study.
Clin Transl Gastroenterol
; 12(3): e00321, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704100
16.
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis.
Clin Mol Hepatol
; 27(2): 329-345, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465844